Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genomeAUSTIN, Texas and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex […]
Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the first GeoMx® Digital Spatial […]
Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potential to build to millions of tests per month The “LamPORE COVID-19” assay provides precise detection of SARS-CoV-2, the virus that causes COVID-19, using Oxford Nanopore’s DNA/RNA sequencing technology. LamPORE is […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics (RADx) […]
Today we launched the Long SIRV module. The long SIRVs are the latest addition to the Spike-In RNA Variants (SIRVs), Lexogen’s portfolio of external RNA reference standards. The 15 RNAs in this module cover the five length categories of 4 kb, 6 b, 8 kb, 10 kb, and 12 kb, each represented by three unique transcripts. […]
Fluidigm among First Seven Companies to Advance in Historic and Rapidly Instituted Program to Support Development and Commercialization of Innovative COVID-19 Testing Technologies SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the […]
Diagenode expands services offering by introducing new high-throughput 3’mRNA sequencing service that utilizes MERCURIUS technology Diagenode, a leading global provider of solutions for epigenetics research and sample preparation, has partnered with Alithea Genomics to provide a novel low cost, high performance 3’ mRNA-seq service to help advance transcriptomics research. The new Alithea-powered technology, known as “MERCURIUS”, enables reliable […]
Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced three of its previously released Research Use Only (RUO) assays are now available […]
University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL consortium collaborate to discover and validate biomarker signatures for predicting response to neoadjuvant and adjuvant immunotherapies Akoya Biosciences, Inc., The Spatial Biology Company™, today announced a collaboration with UCSF Helen Diller Family Comprehensive Cancer Center. […]
Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer. PARIS and SOUTH SAN FRANCISCO, Calif.: DNA Script today announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million. This oversubscribed round is led by […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

